Why the study?
Do novel antidepressant drugs impact cardiovascular disease and arterial hypertension?
Do novel antidepressant drugs impact cardiovascular disease and arterial hypertension?
This review aims to summarize the impact of novel antidepressant drugs on cardiovascular disease and arterial hypertension.
Answers are grounded in this paper and cite their sources.
No immediate change to prescribing in cardiovascular patients; leaves open net effects of novel antidepressants on hypertension and outcomes.
Depression is a common mental health issue worldwide leading to disability, functional decline and increased mortality. Novel antidepressants have been developed during the last decades in order to treat depression syndromes. Some evidence suggests that major depression has been associated with the development of congestive heart failure and with adverse outcomes in patients with coronary heart disease. The purpose of the present article is to review the impact of novel antidepressant patent drugs on cardiovascular disease and arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Katsi et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: